Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Exothera logo — Best-in-class viral vector and nucleic acid development and...

Exothera

Best-in-class viral vector and nucleic acid development and manufacturing services

Founded 2020 Belgium Belgium 161 employees

General Information

Company Name Exothera
Founded Year 2020
Location Belgium Belgium +1
Employees 161
Social

Get notified when Exothera moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exothera

Exothera is a leading contract research, development, and manufacturing organization (CDMO) that focuses on the production of viral vectors and nucleic acids. As a part of the Univercells group, Exothera leverages innovative manufacturing technologies to deliver top-notch bioprocessing expertise. The company's offerings include accelerated discovery services, process development, and optimization aimed at swiftly achieving GMP clinical and commercial production of viral vectors and nucleic acids. Exothera benefits from the support of Univercells and its advanced manufacturing technologies. The company tailors its services to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. With a keen eye on cost-effectiveness and operational agility, Exothera aptly selects technologies to meet the unique needs of its customers. Founded in 2020, Exothera is committed to advancing life-changing therapies and making them accessible to all. The company's dedication to technological innovation and bioprocessing excellence positions it as a key player in the field of viral vector and nucleic acid development and manufacturing services. Company number: 0744643660 VAT: BE0744643660

Taxonomy: Viral vector production, Nucleic acid manufacturing, Bioprocessing expertise, Contract research, Process development, GMP clinical production, Technology-driven, Custom process optimization, mRNA production, Analytical development, QC services

No funding data available for Exothera yet.

Get notified when Exothera raises funding

Exothera Alternatives & Competitors

Exothera vs
IDT Biologika
IDT Biologika Germany

Your full-service CDMO for viral vaccines, cell & gene therapeutics and other biologics protecting h...

500 employees
Health Care, Manufacturing
Exothera vs
CoJourney
CoJourney United States

Reimagining Cell and Gene Therapy CDMO Services High Purity | High Yield | Rapid Turnaround | Reduc...

Series A
7 employees
Biopharma, Health Care
Exothera vs
Genezen
Genezen United States

Bringing Therapies to Life

Growth
272 employees

FAQ About Exothera

Best-in-class viral vector and nucleic acid development and manufacturing services
Exothera was founded in 2020.
Exothera is headquartered in Belgium.
Exothera has approximately 161 employees.
Top alternatives and competitors to Exothera include IDT Biologika, CoJourney, Genezen, Oxford Biomedica, MeiraGTx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exothera and IDT Biologika are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exothera and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy